Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour
- PMID: 29124885
- DOI: 10.1111/obr.12630
Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour
Abstract
Fatty acid ethanolamides are lipid mediators that regulate a plethora of physiological functions. One such bioactive lipid mediator, oleoylethanolamide (OEA), is a potent agonist of the peroxisome proliferator-activated receptor-alpha (PPAR-α), which modulates increased expression of the fatty acid translocase CD36 that enables the regulation of feeding behaviour. Consumption of dietary fat rich in oleic acid activates taste receptors in the gut activating specific enzymes that lead to the formation of OEA. OEA further combines with PPAR-α to enable fat oxidation in the liver, resulting in enhanced energy production. Evidence suggests that sustained ingestion of a high-fat diet abolishes the anorexic signal of OEA. Additionally, malfunction of the enterocyte that transforms oleic acid produced during fat digestion into OEA might be responsible for reduced satiety and hyperphagia, resulting in overweight and obesity. Thus, OEA anorectic signalling may be an essential element of the physiology and metabolic system regulating dietary fat intake and obesity. The evidence reviewed in this article indicates that intake of oleic acid, and thereby the resulting OEA imparting anorexic properties, is dependent on CD36, PPAR-α, enterocyte fat sensory receptors, histamine, oxytocin and dopamine; leading to increased fat oxidation and enhanced energy expenditure to induce satiety and increase feeding latency; and that a disruption in any of these systems will cease/curb fat-induced satiety.
Keywords: Obesity; oleic acid; oleoylethanolamide; satiety.
© 2017 World Obesity Federation.
Similar articles
-
A systematic review of the effects of oleoylethanolamide, a high-affinity endogenous ligand of PPAR-α, on the management and prevention of obesity.Clin Exp Pharmacol Physiol. 2020 Apr;47(4):543-552. doi: 10.1111/1440-1681.13238. Epub 2020 Jan 31. Clin Exp Pharmacol Physiol. 2020. PMID: 31868943
-
The lipid messenger OEA links dietary fat intake to satiety.Cell Metab. 2008 Oct;8(4):281-288. doi: 10.1016/j.cmet.2008.08.005. Cell Metab. 2008. PMID: 18840358 Free PMC article.
-
Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.Neuropharmacology. 2005 Jun;48(8):1147-53. doi: 10.1016/j.neuropharm.2005.02.013. Epub 2005 Apr 21. Neuropharmacology. 2005. PMID: 15910890
-
Feeding regulation by oleoylethanolamide synthesized from dietary oleic acid.Prostaglandins Leukot Essent Fatty Acids. 2021 Feb;165:102228. doi: 10.1016/j.plefa.2020.102228. Epub 2020 Dec 29. Prostaglandins Leukot Essent Fatty Acids. 2021. PMID: 33385936
-
Brain molecules and appetite: the case of oleoylethanolamide.Cent Nerv Syst Agents Med Chem. 2013 Mar;13(1):88-91. doi: 10.2174/1871524911313010010. Cent Nerv Syst Agents Med Chem. 2013. PMID: 23464987 Review.
Cited by
-
The effect of Oleoylethanolamide supplementation on lipid profile, fasting blood sugar and dietary habits in obese people: a randomized double-blind placebo-control trial.BMC Endocr Disord. 2024 Oct 8;24(1):210. doi: 10.1186/s12902-024-01738-7. BMC Endocr Disord. 2024. PMID: 39379951 Free PMC article. Clinical Trial.
-
Emerging mechanisms by which endocannabinoids and their derivatives modulate bacterial populations within the gut microbiome.Adv Drug Alcohol Res. 2023 Dec 8;3:11359. doi: 10.3389/adar.2023.11359. eCollection 2023. Adv Drug Alcohol Res. 2023. PMID: 38389811 Free PMC article. Review.
-
Diurnal Profiles of N-Acylethanolamines in Goldfish Brain and Gastrointestinal Tract: Possible Role of Feeding.Front Neurosci. 2019 May 7;13:450. doi: 10.3389/fnins.2019.00450. eCollection 2019. Front Neurosci. 2019. PMID: 31133788 Free PMC article.
-
The effects of MIND diet and propolis supplementation on metabolic syndrome: A randomized controlled clinical trial.Heliyon. 2024 Jul 14;10(16):e34493. doi: 10.1016/j.heliyon.2024.e34493. eCollection 2024 Aug 30. Heliyon. 2024. PMID: 39220895 Free PMC article.
-
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles.Biomedicines. 2022 Mar 9;10(3):631. doi: 10.3390/biomedicines10030631. Biomedicines. 2022. PMID: 35327432 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources